Cargando…

Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata

The use of broad-spectrum antimycotic therapy, immunosuppressive therapy, and indwelling medical devices has contributed to the increased frequency of mucosal and systemic infections caused by Candida glabrata. A major concern for C. glabrata and other Candida spp. infections is the increase in drug...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Spain, Samantha, Andrade, Pilar I., Brockman, Nohelli E., Fu, Jianmin, Wickes, Brian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225417/
https://www.ncbi.nlm.nih.gov/pubmed/35736079
http://dx.doi.org/10.3390/jof8060596
_version_ 1784733609566928896
author D’Spain, Samantha
Andrade, Pilar I.
Brockman, Nohelli E.
Fu, Jianmin
Wickes, Brian L.
author_facet D’Spain, Samantha
Andrade, Pilar I.
Brockman, Nohelli E.
Fu, Jianmin
Wickes, Brian L.
author_sort D’Spain, Samantha
collection PubMed
description The use of broad-spectrum antimycotic therapy, immunosuppressive therapy, and indwelling medical devices has contributed to the increased frequency of mucosal and systemic infections caused by Candida glabrata. A major concern for C. glabrata and other Candida spp. infections is the increase in drug resistance. To address these issues, additional molecular tools for the study of C. glabrata are needed. In this investigation, we developed an Agrobacterium tumefaciens transformation system for C. glabrata. A number of parameters were investigated to determine their effect on transformation frequency, and then an optimized protocol was developed. The optimal conditions for the transformation of C. glabrata were found to be an infection incubation temperature of 26 °C, 0.2 mM acetosyringone in both induction media and co-culture media, 0.7% agar concentration, and a multiplicity of infection of 50:1 A. tumefaciens to C. glabrata. Importantly, the frequency of multiple integrations was low (5%), demonstrating that A. tumefaciens generally integrates at single sites in C. glabrata, which is consistent with other fungal A. tumefaciens transformation systems. The development of this system in C. glabrata adds another tool for the molecular manipulation of this increasingly important fungal pathogen.
format Online
Article
Text
id pubmed-9225417
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92254172022-06-24 Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata D’Spain, Samantha Andrade, Pilar I. Brockman, Nohelli E. Fu, Jianmin Wickes, Brian L. J Fungi (Basel) Article The use of broad-spectrum antimycotic therapy, immunosuppressive therapy, and indwelling medical devices has contributed to the increased frequency of mucosal and systemic infections caused by Candida glabrata. A major concern for C. glabrata and other Candida spp. infections is the increase in drug resistance. To address these issues, additional molecular tools for the study of C. glabrata are needed. In this investigation, we developed an Agrobacterium tumefaciens transformation system for C. glabrata. A number of parameters were investigated to determine their effect on transformation frequency, and then an optimized protocol was developed. The optimal conditions for the transformation of C. glabrata were found to be an infection incubation temperature of 26 °C, 0.2 mM acetosyringone in both induction media and co-culture media, 0.7% agar concentration, and a multiplicity of infection of 50:1 A. tumefaciens to C. glabrata. Importantly, the frequency of multiple integrations was low (5%), demonstrating that A. tumefaciens generally integrates at single sites in C. glabrata, which is consistent with other fungal A. tumefaciens transformation systems. The development of this system in C. glabrata adds another tool for the molecular manipulation of this increasingly important fungal pathogen. MDPI 2022-06-02 /pmc/articles/PMC9225417/ /pubmed/35736079 http://dx.doi.org/10.3390/jof8060596 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
D’Spain, Samantha
Andrade, Pilar I.
Brockman, Nohelli E.
Fu, Jianmin
Wickes, Brian L.
Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata
title Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata
title_full Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata
title_fullStr Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata
title_full_unstemmed Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata
title_short Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata
title_sort agrobacterium tumefaciens-mediated transformation of candida glabrata
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225417/
https://www.ncbi.nlm.nih.gov/pubmed/35736079
http://dx.doi.org/10.3390/jof8060596
work_keys_str_mv AT dspainsamantha agrobacteriumtumefaciensmediatedtransformationofcandidaglabrata
AT andradepilari agrobacteriumtumefaciensmediatedtransformationofcandidaglabrata
AT brockmannohellie agrobacteriumtumefaciensmediatedtransformationofcandidaglabrata
AT fujianmin agrobacteriumtumefaciensmediatedtransformationofcandidaglabrata
AT wickesbrianl agrobacteriumtumefaciensmediatedtransformationofcandidaglabrata